These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38280977)

  • 1. Targeted mutagenesis in mice via an engineered AsCas12f1 system.
    Fan P; Wang H; Zhao F; Zhang T; Li J; Sun X; Yu Y; Xiong H; Lai L; Sui T
    Cell Mol Life Sci; 2024 Jan; 81(1):63. PubMed ID: 38280977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of genetically modified mice using SpCas9-NG engineered nuclease.
    Fujii W; Ito H; Kanke T; Ikeda A; Sugiura K; Naito K
    Sci Rep; 2019 Sep; 9(1):12878. PubMed ID: 31501500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
    Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
    Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.
    Asano Y; Yamashita K; Hasegawa A; Ogasawara T; Iriki H; Muramoto T
    Sci Rep; 2021 May; 11(1):11163. PubMed ID: 34045481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing mediated by SpCas9 variants with broad non-canonical PAM compatibility in plants.
    Li J; Xu R; Qin R; Liu X; Kong F; Wei P
    Mol Plant; 2021 Feb; 14(2):352-360. PubMed ID: 33383203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
    Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
    Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into a high fidelity variant of SpCas9.
    Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
    Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SpCas9-NG self-targets the sgRNA sequence in plant genome editing.
    Qin R; Li J; Liu X; Xu R; Yang J; Wei P
    Nat Plants; 2020 Mar; 6(3):197-201. PubMed ID: 32094641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9.
    Choi GCG; Zhou P; Yuen CTL; Chan BKC; Xu F; Bao S; Chu HY; Thean D; Tan K; Wong KH; Zheng Z; Wong ASL
    Nat Methods; 2019 Aug; 16(8):722-730. PubMed ID: 31308554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity.
    Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z
    Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed genome editing by a miniature CRISPR-Cas12f nuclease.
    Wu Z; Zhang Y; Yu H; Pan D; Wang Y; Wang Y; Li F; Liu C; Nan H; Chen W; Ji Q
    Nat Chem Biol; 2021 Nov; 17(11):1132-1138. PubMed ID: 34475565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
    Mekler V; Kuznedelov K; Severinov K
    J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the CRISPR Toolbox in
    Veillet F; Perrot L; Guyon-Debast A; Kermarrec MP; Chauvin L; Chauvin JE; Gallois JL; Mazier M; Nogué F
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
    Wang GH; Wang CM; Wu XJ; Chu T; Huang DW; Li J
    Mol Biol (Mosk); 2024; 58(1):157-159. PubMed ID: 38943587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous evolution of SpCas9 variants compatible with non-G PAMs.
    Miller SM; Wang T; Randolph PB; Arbab M; Shen MW; Huang TP; Matuszek Z; Newby GA; Rees HA; Liu DR
    Nat Biotechnol; 2020 Apr; 38(4):471-481. PubMed ID: 32042170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
    Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
    Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.